Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.
Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).
He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times. He was an award-winning political analyst for the USA Radio Network.
Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.
Did the U.S. Shortchange Puerto Rico on Disaster Aid?
Some think Puerto Rico has been shortchanged. The numbers tell a more nuanced story.
Sunburn - The Morning Read of What's Hot in Florida Politics - 5.30.19
“From a political standpoint, it is foolish to push importation. If deaths occur, the politician who promoted it will take the blame,” said Merrill Matthews, a resident scholar with the Institute for Policy Innovation.
Iran Can Rattle Sabers But Not Oil Prices
The Iranian government is rattling sabers once again. In years past those tensions would have sent world oil markets into a panic. Not so this time around.
Protecting Pharmaceutical Patents Is Critical to Our Health
Sen. John Cornyn's legislation that attempts to address problems he sees with the patent protections afforded to American drug companies overreaches and would limit the ability of pharmaceutical firms to develop and improve medicines.
Trump's Climate Modeling Reform Heats Up His Critics
President Trump is making changes in how the EPA deals with climate change because the climate change models are not very reliable—just like some environmental reporters.
New Book Presents Solutions for Financially Insolvent Entitlement Programs
The authors of On the Edge skillfully unravel the mess our political leaders have gotten the nation into over almost 100 years, providing straightforward explanations and direct, simple solutions to the nation’s entitlements crisis.
Finally, a Market-Oriented Way to Help Poor Communities
Finally, Congress passed legislation, led by Sen. Tim Scott, that might just help increase investment in low-income communities, and the regulations were recently released.
One More Example of Why We Need to Rethink the Criminal Justice System
Two men who spent 15 years in jail for a murder they did not commit were recently declared innocent, thanks to the dogged efforts of a group that has shed a light on the failures of our criminal justice system.
Should Incarcerated Felons Be Able to Vote?
It is difficult to see why those guilty of heinous crimes should retain their right to vote.
HHS Rule Fails to Illuminate Complex Drug Pricing Schemes
A new Health and Human Services rule requiring pharmaceutical companies to disclose list prices for medications in commercial advertisements is unlikely to boost price transparency for consumers. In fact, it may create even more confusion.
Total Records: 1735
